Gil-Extremera B - Search Results

1

Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia.

Farnier M, Roth E, Gil-Extremera B, Mendez GF, Macdonell G, Hamlin C, Perevozskaya I, Davies MJ, Kush D, Mitchel YB; Ezetimibe/Simvastatin + Fenofibrate Study Group. Farnier M, et al. Am Heart J. 2007 Feb;153(2):335.e1-8. doi: 10.1016/j.ahj.2006.10.031. Am Heart J. 2007. PMID: 17239698 Clinical Trial.

2

Efficacy and safety of ezetimibe/simvastatin co- administered with fenofibrate in mixed hyperlipidemic patients with metabolic syndrome.

Gil-Extremera B, Mendez G, Zakson M, Meehan A, Shah A, Lin J, Mitchel Y. Gil-Extremera B, et al. Metab Syndr Relat Disord. 2007 Dec;5(4):305-14. doi: 10.1089/met.2007.0011. Metab Syndr Relat Disord. 2007. PMID: 18370800

3

Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia.

Shah S, Ceska R, Gil-Extremera B, Paolini JF, Giezek H, Vandormael K, Mao A, McCrary Sisk C, Maccubbin D. Shah S, et al. Int J Clin Pract. 2010 May;64(6):727-38. doi: 10.1111/j.1742-1241.2010.02370.x. Int J Clin Pract. 2010. PMID: 20518948 Clinical Trial.

4

A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus.

McKie EA, Reid JL, Mistry PC, DeWall SL, Abberley L, Ambery PD, Gil-Extremera B. McKie EA, et al. PLoS One. 2016 Mar 1;11(3):e0150018. doi: 10.1371/journal.pone.0150018. eCollection 2016. PLoS One. 2016. PMID: 26930607 Free PMC article. Clinical Trial.

5

Metabolic and antihypertensive effects of nifedipine in hypertensive patients.

Maldonado Martín A, Quesada Simón MA, Gil Extremera B, Arjona García M, Ruiz Martínez M, Rubio Luengo MA. Maldonado Martín A, et al. J Cardiovasc Pharmacol. 1992;19 Suppl 2:S57-9. doi: 10.1097/00005344-199219002-00014. J Cardiovasc Pharmacol. 1992. PMID: 1377308

6

[Risk factors in the elderly. A study of 143 patients].

Gil Extremera B, Avilés Puertas J, Maldonado Martín A, Fernández Soriano M. Gil Extremera B, et al. An Med Interna. 1997 Oct;14(10):495-9. An Med Interna. 1997. PMID: 9424138 Spanish.

7

Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.

Lacourcière Y, Gil-Extremera B, Mueller O, Byrne M, Williams L. Lacourcière Y, et al. Int J Clin Pract. 2003 May;57(4):273-9. Int J Clin Pract. 2003. PMID: 12800457 Clinical Trial.

8

[Zinc and chronic obstructive pulmonary disease].

León-Espinosa de los Monteros MT, Gil Extremera B, Maldonado Martín A, Luna del Castillo JD, Muñoz Parra F, Ruiz López MF, Huertas Hernández F, Cobo Martínez F. León-Espinosa de los Monteros MT, et al. Rev Clin Esp. 2000 Dec;200(12):649-53. Rev Clin Esp. 2000. PMID: 11234469 Spanish.

9

Lipid disorders in elderly hypertensive patients.

Gil-Extremera B. Gil-Extremera B. Int J Hypertens. 2012;2012:684515. doi: 10.1155/2012/684515. Epub 2011 Dec 29. Int J Hypertens. 2012. PMID: 22254131 Free PMC article.

10

Blood pressure-lowering effects of nifedipine/candesartan combinations in high-risk individuals: subgroup analysis of the DISTINCT randomised trial.

Mancia G, Cha G, Gil-Extremera B, Harvey P, Lewin AJ, Villa G, Kjeldsen SE. Mancia G, et al. J Hum Hypertens. 2017 Mar;31(3):178-188. doi: 10.1038/jhh.2016.54. Epub 2016 Aug 11. J Hum Hypertens. 2017. PMID: 27511476 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page